Expired Tender Russia ICB TOT Ref. 144471883

Supply of the Drug Bortezomib, Lyophilisate Tender - 144471883

Tender notice from Russia, published on 03 Jul 2026.

Executive Summary

The FEDERAL PUBLIC INSTITUTION "FEDERAL CENTER FOR PLANNING AND ORGANIZATION OF MEDICINE PROVISION FOR CITIZENS" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION has issued a Tender notice for the procurement of a Supply of the Drug Bortezomib, Lyophilisate for the Preparation of a Solution for Intravenous and Subcutaneous Administration, 2.5 Mg/Or 3.0 Mg/Or 3.5 Mg as Part of the Implementation of the Resolution of the Government of the Russian Federation O... in the Russia. This Tender notice was published on 03 Jul 2026 and is scheduled to close on 17 Jul 2026, with an estimated Tender value of 615659132.00. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 144471883, while the tender notice number is 0873400003926000553 and Register on the platform.

Key facts

Summary
Supply of the Drug Bortezomib, Lyophilisate for the Preparation of a Solution for Intravenous and Subcutaneous Administration, 2.5 Mg/Or 3.0 Mg/Or 3.5 Mg as Part of the Implementation of the Resolution of the Government of the Russian Federation O...
TOT Ref. No.
144471883
Document Ref. No.
0873400003926000553
Country
Russia
Notice type
Tender
Competition
ICB
Publication date
03 Jul 2026
Bid deadline
17 Jul 2026
EMD
Refer Document
Tender value
615659132.00
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Supply of the drug Bortezomib, lyophilisate for the preparation of a solution for intravenous and subcutaneous administration, 2.5 mg/or 3.0 mg/or 3.5 mg within the framework of the implementation of the resolution of the Government of the Russian Federation deration dated November 26, 2018 No. 1416 On the procedure for organizing the provision of medications to persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher disease, malignant neoplasms and lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic-uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary venous deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as recognition of certain acts of the Government of the Russian Federation as invalid

Documents

Tender Notice
Login to view

Russia Public Procurement Intelligence

Frequently asked questions

The bid deadline for Supply of the Drug Bortezomib, Lyophilisate for the Preparation of a Solution for Intravenous and Subcutaneous Administration, 2.5 Mg/Or 3.0 Mg/Or 3.5 Mg as Part of the Implementation of the Resolution of the Government of the Russian Federation O... was 17 Jul 2026. Bidding is closed.

This tender has been issued by FEDERAL PUBLIC INSTITUTION "FEDERAL CENTER FOR PLANNING AND ORGANIZATION OF MEDICINE PROVISION FOR CITIZENS" OF THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION in Russia.

The estimated tender value is 615659132.00. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 144471883. The purchaser document reference is 0873400003926000553.

Browse other tenders from Russia or search by relevant keywords and CPV classification.